Stigmasterol Glucoside, a Phytosterol Glycoside, Mitigates Systemic Inflammatory Response Syndrome and Liver Injury
Authors:
- 21 January 2026
- journal article
- Published by Wiley in Phytotherapy Research
- Vol. 40 (3) , 1217-1229
Abstract
Stigmasterol glucoside (SG), a phytosterol glycoside derived from plants, is widely distributed in numerous natural sources—particularly medicinal and edible plants—and is recognized to possess potential anti‐inflammatory properties, although its mechanisms of action remain incompletely understood. Experimental results demonstrated that SG significantly attenuated lipopolysaccharide (LPS)‐induced inflammatory responses in RAW264.7 macrophages. In a murine model of systemic inflammatory response syndrome (SIRS) established by LPS challenge, SG effectively mitigated systemic inflammation and ameliorated LPS‐induced hepatic dysfunction. Integrated network pharmacological analysis and transcriptomic sequencing revealed that SG primarily exerts its anti‐inflammatory activity through modulation of the mitogen‐activated protein kinase (MAPK) and signal transducer and activator of transcription 3 (STAT3) signaling pathways, thereby conferring protection against liver injury and systemic inflammation. These findings highlight SG as a promising therapeutic candidate for inflammation‐related disorders.Keywords
This publication has 40 references indexed in Scilit:
- CoF2 nanodots embedded N-doped carbon polyhedrons as a multifunctional interlayer for dendrite-free and stable lithium-sulfur batteriesComposites Part B: Engineering, 2025
- Thermal stability of stigmasterol and β-sitosterol glucosides in fresh-cut bitter melon fruitFood Chemistry, 2024
- Comprehensive phytochemical profiling and biological activities of Hodgsonia heteroclita subsp. indochinensis seed extractsHeliyon, 2024
- Simultaneous analysis of free phytosterols and phytosterol glycosides in rice bran by SPE/GC–MSFood Chemistry, 2022
- Best practice in research – Overcoming common challenges in phytopharmacological researchJournal of Ethnopharmacology, 2020
- Therapeutic potency of mTOR signaling pharmacological inhibitors in the treatment of proinflammatory diseases, current status, and perspectivesJournal of Cellular Physiology, 2017
- Da-Huang-Fu-Zi-Tang attenuates liver injury in rats with severe acute pancreatitisJournal of Ethnopharmacology, 2013
- IL-11 mediated Stat3 activation in inflammation and cancerCytokine, 2009
- Gastrointestinal and Cardiovascular Risks of Nonsteroidal Anti-inflammatory DrugsThe American Journal of Medicine, 2008
- The systemic inflammatory response syndrome and cardiopulmonary bypassInternational Journal of Surgery, 2005